Scinai Immunotherapeutics Ltd.
SCNI
$0.51
-$0.03-5.07%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 0.00% | 67.95% | 0.00% | -49.64% | -23.45% |
| Total Receivables | 0.00% | 20.86% | 0.00% | -35.94% | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 0.00% | -68.22% | 0.00% | 198.73% | -68.86% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 0.00% | 5.63% | 0.00% | 8.40% | 14.75% |
| Total Current Assets | 0.00% | 36.39% | 0.00% | -37.01% | -18.85% |
|
|
|||||
| Total Current Assets | 0.00% | 36.39% | 0.00% | -37.01% | -18.85% |
| Net Property, Plant & Equipment | 0.00% | -7.37% | 0.00% | -6.54% | 1.31% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 0.00% | -1.81% | 0.00% | -11.96% | -5.97% |
|
|
|||||
| Total Accounts Payable | 0.00% | -38.24% | 0.00% | 75.27% | -2.01% |
| Total Accrued Expenses | 0.00% | -- | -- | -- | 39.18% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 0.00% | -33.80% | 0.00% | 17.22% | 3.66% |
| Total Finance Division Other Current Liabilities | 0.00% | -90.66% | 0.00% | 328.44% | -- |
| Total Other Current Liabilities | 0.00% | -90.66% | 0.00% | 328.44% | -- |
| Total Current Liabilities | 0.00% | -25.24% | 0.00% | 17.39% | 15.73% |
|
|
|||||
| Total Current Liabilities | 0.00% | -25.24% | 0.00% | 17.39% | 15.73% |
| Long-Term Debt | 0.00% | 0.34% | 0.00% | 12.69% | 4.12% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 0.00% | 4.98% | 0.00% | 11.70% | -3.16% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | 0.00% | 0.00% | -69.13% |
| Total Liabilities | 0.00% | -11.53% | 0.00% | 14.72% | 3.61% |
|
|
|||||
| Common Stock & APIC | 0.00% | 3.52% | 0.00% | 1.63% | 0.38% |
| Retained Earnings | 0.00% | -3.43% | 0.00% | -3.52% | -1.94% |
| Treasury Stock & Other | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Common Equity | 0.00% | 10.98% | 0.00% | -48.71% | -69.73% |
|
|
|||||
| Preferred Stock Redeemable | 0.00% | 0.00% | 0.00% | 0.00% | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 0.00% | 0.00% | 0.00% | 0.00% | -- |
|
|
|||||
| Total Common Equity | 0.00% | 10.98% | 0.00% | -48.71% | -69.73% |
| Total Preferred Equity | 0.00% | 0.00% | 0.00% | 0.00% | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 0.00% | 3.12% | 0.00% | -21.24% | -69.73% |
|
|
|||||